Akari Therapeutics (AKTX) Stock Chart & Stock Price History $1.15 -0.03 (-2.54%) Closing price 06/18/2025 03:52 PM EasternExtended Trading$1.14 0.00 (-0.43%) As of 06/18/2025 04:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock Akari Therapeutics Stock Price Performance The Akari Therapeutics (AKTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 59.44%, with a year-to-date return of -5.74%. In the past month, the stock has decreased 8.96%, reflecting recent market activity. As of the latest close, Akari Therapeutics traded at $1.15 with a market cap of $37.01 million and volume of 45,916 shares. Five years ago, the stock traded at a split-adjusted price of $41.00, representing a 97.20% decrease over that period. At the time, it had a market cap of $32.99 million and a volume of 9,048 shares. Receive AKTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.36%1 Month Performance-8.96%3 Month Performance-10.85%Year-To-Date Performance-5.74%1 Year Performance-59.44%5 Year Performance-97.20% AKTX Stock Chart for Thursday, June, 19, 2025 AKTX Chart by TradingView Akari Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/18/2025$1.18$1.15-2.54%$1.16$1.1245,916 shs$37.01 million06/17/2025$1.09$1.18+8.26%$1.22$1.1132,955 shs$37.97 million06/16/2025$1.19$1.09-8.40%$1.25$1.0944,670 shs$35.07 million06/13/2025$1.17$1.19+1.64%$1.21$1.0845,410 shs$38.29 million06/12/2025$1.23$1.17-4.42%$1.26$1.1764,878 shs$37.67 million06/11/2025$1.28$1.23-3.92%$1.30$1.2142,866 shs$39.42 million06/10/2025$1.25$1.28+2.00%$1.30$1.2039,321 shs$41.02 million06/09/2025$1.29$1.25-2.72%$1.28$1.2411,853 shs$40.22 million06/06/2025$1.31$1.29-1.91%$1.31$1.226,267 shs$41.35 million06/05/2025$1.35$1.31-2.96%$1.35$1.2716,751 shs$42.15 million Get the Latest News and Ratings for AKTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/04/2025$1.35$1.35-0.01%$1.39$1.3522,916 shs$43.43 million06/03/2025$1.42$1.35-4.59%$1.40$1.3410,466 shs$43.44 million06/02/2025$1.30$1.42+8.85%$1.42$1.2721,614 shs$45.53 million05/30/2025$1.30$1.30+0.39%$1.35$1.2024,388 shs$41.83 million05/29/2025$1.30$1.30-0.38%$1.30$1.296,576 shs$41.67 million05/28/2025$1.28$1.30+1.56%$1.30$1.2716,908 shs$41.83 million05/27/2025$1.28$1.28+0.39%$1.33$1.247,471 shs$41.19 million05/26/2025$1.28$1.28$1.37$1.2113,550 shs$41.02 million05/23/2025$1.28$1.28$1.37$1.2113,550 shs$41.02 million05/22/2025$1.24$1.28+2.82%$1.25$1.251,823 shs$33.91 million05/21/2025$1.30$1.24-4.59%$1.39$1.2312,358 shs$32.98 million05/20/2025$1.26$1.30+2.88%$1.30$1.291,730 shs$34.56 million05/19/2025$1.27$1.26-0.54%$1.30$1.232,620 shs$33.59 million Related Companies Neumora Therapeutics Stock Chart RAPT Therapeutics Stock Chart Kyverna Therapeutics Stock Chart Black Diamond Therapeutics Stock Chart Nkarta Stock Chart Lexeo Therapeutics Stock Chart Korro Bio Stock Chart FitLife Brands Stock Chart Greenwich LifeSciences Stock Chart Protara Therapeutics Stock Chart Receive AKTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AKTX) was last updated on 6/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akari Therapeutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Akari Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AKTX Stock Free AKTX Stock Alerts